Investor FAQs

Show all

240 Leigh Farm Road, Suite 245, Durham, NC 27707
Delaware
June 28, 2017
January 1 – December 31
The NASDAQ Global Market under the symbol “DOVA”
We have never declared or paid any dividends on our common stock. We anticipate that we will retain all of our future earnings, if any, for use in the operation and expansion of our business and do not anticipate paying cash dividends in the foreseeable future.
American Stock Transfer & Trust Company. You can find more information at https://www.amstock.com.
Contact our transfer agent, American Stock Transfer & Trust Company at https://www.amstock.com/shareholder/sh_faqs.asp. They can look up your records and make any necessary adjustments. There is a fee involved for replacing lost certificates.
Dova Pharmaceuticals does not offer a direct stock purchase plan.
KPMG LLP
This information is available at www.dova.com.
This information is available at www.dova.com in the “Investor Relations” section of our corporate website.
Quarterly and Annual reports and other investor materials are available under “SEC Filings” of the “Investor Relations” section of our corporate website. Additionally, all SEC filings can be accessed directly from the SEC at www.sec.gov.
This information is available at www.dova.com.
For investor-related questions, please visit the “Investor Relations” section of our corporate website and choose “IR Resources – Contact IR”.
Please visit the “Investor Relations” section of our corporate website and choose the “IR Resources – Email Alerts”  to be added to the Dova Pharmaceuticals distribution list.

Investor FAQs